EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Expression of Lumican and Osteopontin in Perivascular Areas of the Glioblastoma Peritumoral Niche and Its Value for Prognosis

María Dolores Salinas iD, Pablo Rodriguez, Gonzalo Rubio iD, Rut Valdor iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms26010192 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von María Dolores Salinas und 3 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry, Molecular Biology B and Immunology Department, University of Murcia (UMU), 30120 Murcia, Spain. Hauptthemen laut MEDLINE: Lumican, Osteopontin, Glioblastoma, Tumor Microenvironment. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MCIN/AEI/10.13039/501100011033, as "ESF Investing in your future, MCIN/AEI/10.13039/501100011033, Seneca Foundation "Agencia de Ciencia y Tecnología de la Región de Murcia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GB) is one of the most aggressive and treatment-resistant cancers due to its complex tumor microenvironment (TME). We previously showed that GB progression is dependent on the aberrant induction of chaperone-mediated autophagy (CMA) in pericytes (PCs), which promotes TME immunosuppression through the PC secretome. The secretion of extracellular matrix (ECM) proteins with anti-tumor (Lumican) and pro-tumoral (Osteopontin, OPN) properties was shown to be dependent on the regulation of GB-induced CMA in PCs. As biomarkers are rarely studied in TME, in this work, we aimed to validate Lumican and OPN as prognostic markers in the perivascular areas of the peritumoral niche of a cohort of GB patients. Previously, we had validated their expression in GB xenografted mice presenting GB infiltration (OPN) or GB elimination (Lumican) dependent on competent or deficient CMA PCs, respectively. Then, patient sample classification by GB infiltration into the peritumoral brain parenchyma was related to GB-induced CMA in microvasculature PCs, analyzing the expression of the lysosomal receptor, LAMP-2A. Our results revealed a correlation between GB-induced CMA activity in peritumoral PCs and GB patients’ outcomes, identifying three degrees of severity. The perivascular expression of both immune activation markers, Iba1 and CD68, was related to CMA-dependent PC immune function and determined as useful for efficient GB prognosis. Lumican expression was identified in perivascular areas of patients with less severe outcome and partially co-localizing with PCs presenting low CMA activity, while OPN was primarily found in perivascular areas of patients with poor outcome and partially co-localizing with PCs presenting high CMA activity. Importantly, we found sex differences in the incidence of middle-aged patients, being significantly higher in men but with worse prognosis in women. Our results confirmed that Lumican and OPN in perivascular areas of the GB peritumoral niche are effective predictive biomarkers for evaluating prognosis and monitoring possible therapeutic immune responses dependent on PCs in tumor progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LumicanOsteopontinGlioblastomaTumor MicroenvironmentBrain NeoplasmsHumansPrognosisFemaleAnimalsMaleMicePericytesBiomarkers, TumorMiddle AgedAutophagyAged

Stichwörter der Autor:innen

CD68CMAIba-1LAMP-2Abiomarkerglioblastomalumicanosteopontinpericyteperitumoralperivascularsex differencestumor microenvironment

Substanzen

LumicanOsteopontinLUM protein, humanBiomarkers, TumorSPP1 protein, human

Autor:innen und Institutionen

  • Biochemistry, Molecular Biology B and Immunology Department, University of Murcia (UMU), 30120 Murcia, Spain.
  • Unit of Autophagy, Immune Response and Tolerance in Pathologic Processes, Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain.

ORCID-Profile: María Dolores Salinas, Gonzalo Rubio, Rut Valdor

Förderung

  • MCIN/AEI/10.13039/501100011033, as "ESF Investing in your future
  • MCIN/AEI/10.13039/501100011033
  • Seneca Foundation "Agencia de Ciencia y Tecnología de la Región de Murcia
  • MCIN/AEI/10.13039/501100011033, as “ESF Investing in your future”
  • Seneca Foundation “Agencia de Ciencia y Tecnología de la Región de Murcia”

Zitieren

APA

Salinas, M. D., Rodriguez, P., Rubio, G., & Valdor, R. (2024). Expression of Lumican and Osteopontin in Perivascular Areas of the Glioblastoma Peritumoral Niche and Its Value for Prognosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26010192

Vancouver

Salinas MD, Rodriguez P, Rubio G, Valdor R. Expression of Lumican and Osteopontin in Perivascular Areas of the Glioblastoma Peritumoral Niche and Its Value for Prognosis. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms26010192

BibTeX
@article{Salinas2024,
  author = {Salinas, María Dolores and Rodriguez, Pablo and Rubio, Gonzalo and Valdor, Rut},
  title = {Expression of Lumican and Osteopontin in Perivascular Areas of the Glioblastoma Peritumoral Niche and Its Value for Prognosis},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms26010192}
}
Kostenlos starten →